On 12 Oct 2026, Scarnose International was priced at ₹37.40, or 1870.0× trailing earnings, and the shares are 58% below their 52-week high. It earns ROCE of 0.1% and ROE of 0.1%, and sales and net profit fell 37% and 46% a year over 3 years, though net profit is above operating profit, which points to a one-off gain. It is a small-cap company with a market cap of ₹12 Cr; the shares fell 35% over the past year.
- ₹37.40
- ₹37.40
- ₹37.40
- ₹37.40
- 2K
Health check
- ReturnsWeak
−34.9% over the past year.
- Price tagDistorted
A one-off gain inflates profit, so P/E isn’t comparable right now.
- GrowthShrinking
Sales −37.1%, profit −46.3% a year over 3 years.
- ProfitabilityWeak
ROCE 0.1%.
- Balance sheetn/a
Balance sheet figures aren’t reported.
- Red flags5 to check
Return on equity is low at 0.1%.
Small cap
Market sensitivity
Key metrics
- Market cap
- ₹12 Cr
- Small cap
- P/E
- 1870.0
- Price to book
- 1.21
- Book value ₹30.87
- Dividend yield
- 0.00%
- ROE
- 0.1%
- Return on equity
- ROCE
- 0.1%
- Return on capital employed
- Debt to equity
- n/a
- Debt ₹0.00 Cr
- EPS (TTM)
- ₹0.02
- OPM (TTM)
- −8.1%
- Net margin 0.1%
- Sales growth
- −14.1%
- Latest quarter vs a year ago
- Profit growth
- n/a
- Year-ago quarter not reported
- Price to sales
- 1.15
- EV/EBITDA −220.6
Strengths and risks
Risks to check
- Return on equity is low at 0.1%.
- Quarterly sales down 14.1% on a year ago.
- Net profit is above operating profit, so a one-off gain is likely flattering earnings.
- 58% below its 52-week high.
- Interest coverage of only −31.1×.
About Scarnose International
Scarnose International Limited engages in the manufacturing, trading, warehousing, clearing, forwarding, purchasing, selling, and marketing of active pharmaceutical ingredients in India. It also provides oncology drugs, antibiotics, vaccines, pharmaceutical formulations, personal hygiene products, fertilizers, and agricultural chemicals. The company was founded in 2002 and is based in Rajkot, India.
- Headquarters
- Rajkot
- Sector
- Consumer Cyclical
- ISIN
- INE0IXR01019
- Website
- scarnose.in
Price range
- Avg volume (3M)
- 596
- 1-year return
- minus 34.9%
- From 52-week high
- minus 58.4%
Peers
We couldn’t find listed peers for this company.
Quarterly results
This company doesn’t report these figures in a format we can read yet.
Profit & loss
- Sales CAGR 3Y
- −37.1%
- Profit CAGR 3Y
- −46.3%
- ROE
- 0.1%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 41.1 | 13.9 | 12.1 | 10.2 | |
| – | minus 66.2% | minus 12.7% | minus 15.6% | |
| 41.1 | 14.1 | 12 | 10.3 | |
| −0.1 | −0.2 | 0.1 | −0.1 | |
| −0.2% | −1.8% | 0.8% | −0.5% | |
| 0.2 | 0.3 | 0.2 | 0.1 | |
| 0 | 0 | – | 0 | |
| 0 | 0 | 0 | 0 | |
| −0 | −0 | −0 | – | |
| 0.1 | 0 | 0.3 | 0 | |
| 23.9% | 29.5% | 24.6% | 25.6% | |
| 0 | 0 | 0.2 | 0 | |
| – | minus 78.6% | +1953.8% | minus 96.5% | |
| 0.15 | 0.03 | 0.61 | – |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 3.2 | 3.2 | 3.2 | 3.2 | |
| 6.9 | 6.4 | 6.6 | 6.6 | |
| 0 | – | – | – | |
| 5.1 | 0 | 0.2 | 0.1 | |
| 15.1 | 9.6 | 9.9 | 9.8 | |
| 0.1 | 0.1 | 0 | 0 | |
| 0.1 | 0.1 | 0.1 | 0.1 | |
| 0.5 | 0.1 | 0 | 0.1 | |
| 14.5 | 9.3 | 9.8 | 9.6 | |
| 15.1 | 9.6 | 9.9 | 9.8 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| −5.4 | −0.6 | 0.2 | −2 | |
| −0.8 | 0.3 | −0.5 | 2 | |
| 6.6 | −0 | – | −0 | |
| 0.3 | −0.3 | −0.3 | −0 | |
| −0 | – | – | – | |
| −5.4 | −0.6 | 0.2 | −2 |
Shareholding pattern
This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.
Major shareholders
Filings & events
News
No recent news coverage found.